CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S21, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER Ponce LN, Brizuela NY. Cátedra de Farmacología General. Facultad de Ciencias Médicas .Universidad Nacional de Córdoba. Argentina. E-mail: … Continue reading CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

J Pharm Pharmacogn Res 2(Suppl. 1): S21, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

Ponce LN, Brizuela NY.

Cátedra de Farmacología General. Facultad de Ciencias Médicas .Universidad Nacional de Córdoba. Argentina. E-mail: lucinuri2011@gmail.com
Abstract

Introduction: Pharmacotherapy in the elderly population is complicated by several factors that increase the risk of drugs. Rational use of medicines refers to the correct, proper and appropriate use of medicines. More than 50% of all medicines are prescribed, dispensed or sold inappropriately, and half of all patients fail to take medicines correctly. This article aims to highlight the increasing impact of polypharmacy in the elderly patients.

Methodology: The present study is prospective in nature, descriptive, cross sectional, carried out between February and May 2011, in a primary care clinic at a senior center in the city of Cordoba, Argentina.

Results: In this sample, 74.21% used from 5 to 8 medicines daily; all of them used to take each medication at least 3 times daily. In this sample, 73.04% had increased risk of adverse drug reaction (ADRs) and 78% came from different physicians. A third (34%) of the patients was treated predominately with cardiovascular diseases drugs. Metabolic diseases (25%), digestive illness (14.5%), neurological and psychiatric disorders (14.5%) and the others (14.5%). A quarter (25%) of the patients was treated with very little therapeutic value drugs.

Conclusions: Polypharmacy, as well as inappropriate prescribing, for the elderly is a major problem and a challenge that contributes to costs, adverse drug events, confusion, compliance issues, and errors in management. A systematic approach to drug monitoring is an important aspect of appropriate prescribing. Attention to prescribing of medications, consistent review of medication lists, and reevaluation of indications and outcomes of prescribing are essential to ensure that polypharmacy is minimized and safety for patients is maximized.

Anti-obesity activity of Cymbopogon citratus
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1090-1110, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres24.1989_12.6.1090 Review Anti-obesity activity of Cymbopogon citratus (lemongrass): A systematic review [Actividad antiobesidad de Cymbopogon citratus (hierba limón): Una revisión sistemática] Musthika Wida Mashitah1,2*, Nashi Widodo3, Nur Permatasari4, Achmad Rudijanto5 1Department of Nursing, Faculty of Health Sciences, Institute of Technology, Science and … Continue reading Anti-obesity activity of Cymbopogon citratus
Multicomponent crystals increase simvastatin solubility
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1079-1089, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres23.1898_12.6.1079 Original Article Multicomponent crystals: Solubility enhancement of simvastatin using arginine and glycine coformers [Cristales multicomponentes: Mejora de la solubilidad de la simvastatina utilizando coformadores de arginina y glicina] Iyan Sopyan1,2*, Karyn Elizabeth1, Sandra Megantara3, Silmy Kaffah1 1Department of Pharmaceutics and Pharmaceutical … Continue reading Multicomponent crystals increase simvastatin solubility
Phyllanthus emblica flavonoid glycosides against xanthine oxidase
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1067-1078, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres24.1959_12.6.1067 Original Article Antioxidant potential and xanthine oxidase inhibition of flavonol glycosides from Phyllanthus emblica L. leaves [Potencial antioxidante e inhibición de la xantina oxidasa de los glucósidos de flavonol de las hojas de Phyllanthus emblica L.] Husnunnisa1, Rika Hartati1, Rachmat Mauludin2, … Continue reading Phyllanthus emblica flavonoid glycosides against xanthine oxidase

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio